These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12677207)

  • 1. Tumor Necrosis Factor and Drug Delivery in the Blood-Brain Barrier.
    Albensi BC
    Drug News Perspect; 2002 May; 15(4):233-237. PubMed ID: 12677207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transport of drugs across the blood-brain barrier].
    Breimer DD
    Verh K Acad Geneeskd Belg; 1998; 60(1):47-60; discussion 60-1. PubMed ID: 9646722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of shear stress induces leukocyte-mediated cytokine release and blood-brain barrier failure in dynamic in vitro blood-brain barrier model.
    Krizanac-Bengez L; Mayberg MR; Cunningham E; Hossain M; Ponnampalam S; Parkinson FE; Janigro D
    J Cell Physiol; 2006 Jan; 206(1):68-77. PubMed ID: 15920760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier.
    Mayhan WG
    Brain Res; 2002 Feb; 927(2):144-52. PubMed ID: 11821008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide.
    Hartz AM; Bauer B; Fricker G; Miller DS
    Mol Pharmacol; 2006 Feb; 69(2):462-70. PubMed ID: 16278373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain and the blood-brain barrier: obstacles to drug delivery.
    Wolka AM; Huber JD; Davis TP
    Adv Drug Deliv Rev; 2003 Aug; 55(8):987-1006. PubMed ID: 12935941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier.
    Nadeau S; Rivest S
    Neuroscience; 1999; 93(4):1449-64. PubMed ID: 10501470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The blood-brain barrier and drug delivery in the central nervous system].
    Loch-Neckel G; Koepp J
    Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IP-10 Promotes Blood-Brain Barrier Damage by Inducing Tumor Necrosis Factor Alpha Production in Japanese Encephalitis.
    Wang K; Wang H; Lou W; Ma L; Li Y; Zhang N; Wang C; Li F; Awais M; Cao S; She R; Fu ZF; Cui M
    Front Immunol; 2018; 9():1148. PubMed ID: 29910805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
    Saunders NR; Habgood MD; Møllgård K; Dziegielewska KM
    F1000Res; 2016; 5():. PubMed ID: 26998242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport Across the Blood-Brain Barrier.
    Fu BM
    Adv Exp Med Biol; 2018; 1097():235-259. PubMed ID: 30315549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of blood-brain barrier permeability in brain tumor imaging and therapeutics.
    Provenzale JM; Mukundan S; Dewhirst M
    AJR Am J Roentgenol; 2005 Sep; 185(3):763-7. PubMed ID: 16120931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
    Pan W; Banks WA; Kastin AJ
    Exp Neurol; 1997 Aug; 146(2):367-73. PubMed ID: 9270046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit.
    Brown JA; Codreanu SG; Shi M; Sherrod SD; Markov DA; Neely MD; Britt CM; Hoilett OS; Reiserer RS; Samson PC; McCawley LJ; Webb DJ; Bowman AB; McLean JA; Wikswo JP
    J Neuroinflammation; 2016 Dec; 13(1):306. PubMed ID: 27955696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.
    Vazana U; Veksler R; Pell GS; Prager O; Fassler M; Chassidim Y; Roth Y; Shahar H; Zangen A; Raccah R; Onesti E; Ceccanti M; Colonnese C; Santoro A; Salvati M; D'Elia A; Nucciarelli V; Inghilleri M; Friedman A
    J Neurosci; 2016 Jul; 36(29):7727-39. PubMed ID: 27445149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
    Zünkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ; Dedrick RL; Herscovitch P; Oldfield EH
    J Neurosurg; 1996 Dec; 85(6):1056-65. PubMed ID: 8929495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.